Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in over-the-counter and prescription creams, ointments and injectables in the fields of dermatology, neurology and metabolic disorders.
Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease.
Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including Mederma scar gel).
In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and Xeomin).
This site uses cookies to offer you an optimized and personalized user experience, to make our audience statistics, or to offer you advertising and offers tailored to your desires and interests. You can, however, uncheck the cookies that you do not want us to use.
Technical cookies are necessary for the functioning of the site and can not be disabled. However, they are only collected and used during your presence on this site.
